Author: Customer Service

OwlPay Harbor payment volume grew approximately 15-fold from April to September 2026, rising for eight consecutive months, as the Company builds regulated payment infrastructure for software platforms, financial institutions and AI agentsARLINGTON, Va., Oct. 19, 2026 (GLOBE NEWSWIRE) — Owlting Group (NASDAQ: OWLS) (“Owlting” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company building regulated payment infrastructure, today published a letter to shareholders from Founder and CEO Darren Wang marking the first anniversary of the Company’s Nasdaq listing on October 16, 2025. In the letter, Mr. Wang reviews the Company’s first year as a public company, the early commercial performance of OwlPay Harbor,1 the regulated payment infrastructure behind it, and the long-term...

CALGARY, Alberta , Oct. 19, 2026 (GLOBE NEWSWIRE) — Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug discovery company developing novel therapeutics for autism spectrum disorder (“ASD”) and related neurodevelopmental disorders, is pleased to announce that it has selected CMAX as the Phase I clinical site to test its lead drug candidate MB-204, an important step in the Company’s preparations to advance its lead patented drug candidate toward first-in-human clinical evaluation. CMAX Clinical Research is an independent clinical research facility, based in Adelaide, Australia. CMAX has been established as a Phase I unit since December 1993, making it the longest-running in Australia and, since establishment, has consistently...

Late-breaking oral presentation will feature first data from the global ROSETTA Lung-107 Phase 2 clinical trial evaluating pumitamig, a PD-L1×VEGF-A bispecific immunomodulator, plus docetaxel in patients with metastatic non-small cell lung cancer following prior immunotherapy plus chemotherapy Global Phase 2 data for pumitamig plus elfetabart drozuntecan, a B7-H3-targeting antibody-drug conjugate, expand the body of evidence for this novel-novel combination in multiple advanced solid tumors Updates from across the pumitamig clinical development program underscore its pan-tumor potential, including in lung and breast cancer patients with brain metastases and patients with neuroendocrine neoplasmsMAINZ, Germany, October 19, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its late-stage...

MONACO, Oct. 19, 2026 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers,” or the “Company”) announced today that on Wednesday, October 28, 2026, the Company plans to issue its third quarter 2026 earnings press release in the morning (Eastern Daylight Time) and host a conference call at 8:00 AM Eastern Daylight Time and 1:00 PM Central European Time. Conference Call Information Title: Scorpio Tankers Inc. Third Quarter 2026 Conference Call Date: Wednesday October 28, 2026 Time: 8:00 AM Eastern Daylight Time and 1:00 PM Central European Time The conference call will be available over the internet, through the Scorpio Tankers Inc. website www.scorpiotankers.com and the webcast link: https://edge.media-server.com/mmc/p/etyipqgc Participants for the live webcast should register on the website...

Peterson den Helder BV has exercised option for Havila Borg through 1 September 2027,The contract has further option periods totaling 15 months. Contacts:Chief Executive Officer Njål Sævik, +47 909 35 722Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

STEINHAUSEN, Switzerland, Oct. 19, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced contract awards for two of its ultra-deepwater drillships in the U.S. Gulf. In aggregate, the fixtures represent approximately $550 million in firm contract backlog. The Deepwater Proteus was awarded a ten-well contract with an undisclosed operator in the U.S. Gulf. The estimated 700-day campaign is expected to contribute approximately $325 million in backlog and commence in the first quarter of 2027 in direct continuation of the rig’s current U.S. Gulf contract. The Deepwater Conqueror was awarded a five-well contract with an undisclosed operator in the U.S. Gulf. The estimated 450 days of work is expected to contribute approximately $225 million in backlog, excluding mobilization fees, and commence in the third...

Strategic acquisition of Perfectum strengthens Beeline Uzbekistan’s competitive position, expands spectrum resources and creates new opportunities for growth in 5G, broadband and digital Dubai, New York & Tashkent, [19 October 2026]– VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), today announces that it has agreed to acquire 100% of Rubicon Wireless, the mobile network operator trading under the “Perfectum” brand, a mobile network operator in Uzbekistan. The acquisition will bring complementary spectrum and network assets into VEON’s operations in Uzbekistan, strengthening Beeline Uzbekistan’s ability to deliver better connectivity, expand broadband access and support the country’s growing demand for digital services, financial services and sovereign augmented intelligence further contributing to the...